AbbVie closes $7.75B debt offering across seven tranches (2028-2066)

AbbVie Inc.

Completed public offering of $750M floating rate notes due 2028 and $7B in fixed rate notes (3.775% to 5.650%) maturing 2028-2066.
Largest tranches: $1.5B of 3.775% notes due 2028 and $1.5B of 4.750% notes due 2036.
Longest maturity: $500M of 5.650% senior notes due 2066.
Notes are unsecured, unsubordinated, and rank equally with existing unsecured debt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.